Eastman Chemical Co. (0IF3)
London Exchange · UK · prices in USD · close of 15 Oct 2026
Key indicators
| Last close | USD 64.21 |
|---|---|
| 52-week range | 56.50 – 82.61 |
| Return, 1 month / 3 months | −3.4% / −4.1% |
| Return, 1 year / 3 years | +11.5% / −0.6% |
| Trend | Below its 200-day average |
| RSI (14) | 44 |
| Volatility (1 year) | 31.6% |
| Worst drawdown (1 year) | -21.0% |
| Average daily value traded | 0.01M USD |
| Dividend yield | 5.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Eastman Chemical Company is a specialty materials company that makes chemicals, plastics and fibers for industrial customers. Its products include specialty plastics used in packaging and consumer goods, coatings additives, adhesives, and acetate yarns for textiles. Customers are manufacturers and processors across markets such as transportation, building and construction, and consumer products. The company is based in Kingsport, Tennessee, in the United States, and serves customers around the world.
On this site Eastman Chemical Co. appears as a stock on the London Exchange (UK), code 0IF3, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Eastman Chemical Co. (0IF3) trades on the London Exchange in UK. It last closed at USD 64.21 on 15 October 2026.
Its price-based Market X-Ray is 47 out of 100 (a weak price profile), ranking 2,215 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 11.5% and over the last three months it fell 4.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 38 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -7.6% | ||
| From 52-week high | -21.4% | ||
| Momentum | 47 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -4.1% | ||
| 6-month return | -8.2% | ||
| 12-month return, skipping the last month | 15.4% | ||
| Stability (higher is calmer) | 64 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 31.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.0% | ||
| Liquidity | 14 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 81 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 5.2% | ||
| Years with dividends | 6 |
Strengths
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +2.0% |
|---|---|
| 1 month | −3.4% |
| 3 months | −4.1% |
| 6 months | −8.2% |
| 1 year | +11.5% |
| 3 years | −0.6% |
| 5 years | – |
Signals
| 50-day / 200-day average | 68.42 / 69.48 |
|---|---|
| Golden / death cross (60 days) | Death, 10 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.80 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 14 Sep 2026 | USD 0.8400 |
| 12 Jun 2026 | USD 0.8400 |
| 12 Mar 2026 | USD 0.8400 |
| 12 Dec 2025 | USD 0.8400 |
| 12 Sep 2025 | USD 0.8300 |
| 12 Jun 2025 | USD 0.8300 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.